Viewing Study NCT02126358


Ignite Creation Date: 2025-12-25 @ 12:08 AM
Ignite Modification Date: 2025-12-31 @ 10:10 PM
Study NCT ID: NCT02126358
Status: COMPLETED
Last Update Posted: 2016-10-18
First Post: 2014-03-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Gemigliptin-Rosuvastatin Fix-dose Combination Phase 3(BALANCE)
Sponsor: LG Life Sciences
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module